The management of diverse cancers has been revolutionized by the three crucial chemotherapeutic substances: osimertinib, pemetrexed, and carboplatin.Combined, these drugs present a promising method for addressing tumor cells and enhancing patient results.The article aims to provide a detailed examination of the modes of action, possible adverse effects, and the benefits in cancer therapy offered by osimertinib, pemetrexed, and carboplatin.cellular death is caused within tumor cells by osimertinib, pemetrexed, and carboplatin through interference in DNA duplication and repair mechanisms.specifically aiming at epidermal growth factor receptor alterations in NSCLC (NSCLC), osimertinib is…
